Optinose Stock Today
| OPTN Stock | USD 0.97 0.06 5.83% |
Performance0 of 100
| Odds Of DistressOver 86
|
OptiNose is selling at 0.97 as of the 24th of April 2024; that is -5.83 percent decrease since the beginning of the trading day. The stock's open price was 1.03. OptiNose has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for OptiNose are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 13th of October 2017 | Category Healthcare | Classification Health Care |
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. The company has 112.65 M outstanding shares of which 3.11 M shares are now shorted by private and institutional investors with about 3.2 trading days to cover. More on OptiNose
Moving together with OptiNose Stock
| 0.65 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.66 | BMY | Bristol Myers Squibb Earnings Call Tomorrow | PairCorr |
Moving against OptiNose Stock
| 0.59 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.48 | ELYM | Eliem Therapeutics | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 9th of May 2024
OptiNose Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OptiNose's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OptiNose or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Peter Miller | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering OptiNose report their recommendations after researching OptiNose's financial statements, talking to executives and customers, or listening in on OptiNose's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering OptiNose. The OptiNose consensus assessment is calculated by taking the average forecast from all of the analysts covering OptiNose. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from OptiNose's historical financial statements, OptiNose may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of OptiNose is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OptiNose's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to OptiNose's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand OptiNose's financial leverage. It provides some insight into what part of OptiNose's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OptiNose (OPTN) is traded on NASDAQ Exchange in USA. It is located in 1020 Stony Hill Road, Yardley, PA, United States, 19067 and employs 132 people. OptiNose is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 116.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OptiNose's market, we take the total number of its shares issued and multiply it by OptiNose's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OptiNose conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 112.65 M outstanding shares of which 3.11 M shares are now shorted by private and institutional investors with about 3.2 trading days to cover.
OptiNose currently holds about 78.26 M in cash with (20.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94.
Check OptiNose Probability Of Bankruptcy
Ownership AllocationOptiNose owns a total of 112.65 Million outstanding shares. The majority of OptiNose outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in OptiNose to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in OptiNose. Please pay attention to any change in the institutional holdings of OptiNose as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check OptiNose Ownership Details
OptiNose Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of OptiNose jumping above the current price in 90 days from now is about 97.0%. The OptiNose probability density function shows the probability of OptiNose stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.3292. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, OptiNose will likely underperform. Additionally, optiNose has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of OptiNose to move above the current price in 90 days from now is about 97.0 (This OptiNose probability density function shows the probability of OptiNose Stock to fall within a particular range of prices over 90 days) .
OptiNose Stock Institutional Holders
Institutional Holdings refers to the ownership stake in OptiNose that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of OptiNose's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing OptiNose's value.| Instituion | Recorded On | Shares | |
| Easterly Investment Partners. | 2023-12-31 | 1.5 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1.5 M | |
| State Street Corporation | 2023-12-31 | 1.3 M | |
| Rice Hall James & Associates, Llc | 2023-12-31 | 1 M | |
| Northern Trust Corp | 2023-12-31 | 615.3 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 384.2 K | |
| Bridgeway Capital Management, Llc | 2023-12-31 | 338.1 K | |
| Springbok Capital Management, Llc | 2023-12-31 | 270 K | |
| Gmt Capital Corp | 2023-12-31 | 240.9 K | |
| Fmr Inc | 2023-12-31 | 14.7 M | |
| Mvm Partners Llc | 2023-12-31 | 14.6 M |
OptiNose Historical Income Statement
OptiNose Income Statement is one of the three primary financial statements used for reporting OptiNose's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of OptiNose revenue and expense. OptiNose Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, OptiNose's Non Operating Income Net Other is very stable compared to the past year. View More FundamentalsOptiNose Stock Against Markets
Picking the right benchmark for OptiNose stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in OptiNose stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for OptiNose is critical whether you are bullish or bearish towards OptiNose at a given time. Please also check how OptiNose's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in OptiNose without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
OptiNose Corporate Directors
OptiNose corporate directors refer to members of an OptiNose board of directors. The board of directors generally takes responsibility for the OptiNose's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of OptiNose's board members must vote for the resolution. The OptiNose board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Sandra Helton | Independent Director | Profile | |
| Joshua Tamaroff | Independent Director | Profile | |
| Sriram Venkataraman | Independent Director | Profile | |
| Wilhelmus Groenhuysen | Independent Director | Profile |
How to buy OptiNose Stock?
Before investing in OptiNose, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in OptiNose. To buy OptiNose stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of OptiNose. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase OptiNose stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located OptiNose stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased OptiNose stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as OptiNose, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy OptiNose Stock please use our How to Invest in OptiNose guide.
Already Invested in OptiNose?
The danger of trading OptiNose is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of OptiNose is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than OptiNose. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile OptiNose is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for OptiNose Stock analysis
When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is OptiNose's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Revenue Per Share 0.633 | Quarterly Revenue Growth (0.05) | Return On Assets (0.11) | Return On Equity (10.51) |
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.